AR045794A1 - Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico - Google Patents
Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinicoInfo
- Publication number
- AR045794A1 AR045794A1 ARP040103395A ARP040103395A AR045794A1 AR 045794 A1 AR045794 A1 AR 045794A1 AR P040103395 A ARP040103395 A AR P040103395A AR P040103395 A ARP040103395 A AR P040103395A AR 045794 A1 AR045794 A1 AR 045794A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- amino
- reacting
- hydroxypropylphosphinic
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 abstract 2
- 230000007062 hydrolysis Effects 0.000 abstract 2
- 238000006460 hydrolysis reaction Methods 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- OWOIXRFDMCACSM-UHFFFAOYSA-N (3-azaniumyl-2-hydroxypropyl)-hydroxyphosphinate Chemical class NCC(O)CP(O)(O)=O OWOIXRFDMCACSM-UHFFFAOYSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- HOCOIDRZLNGZMV-UHFFFAOYSA-N ethoxy(oxido)phosphanium Chemical group CCO[PH2]=O HOCOIDRZLNGZMV-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/306—Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente se refiere a un procedimiento para preparar derivados de ácido 3-amino-2-hidroxipropilfosfónico, que son valiosos ingredientes activos farmacéuticos y pueden ser empleados, por ejemplo, como antidepresivos. Reivindicación 1: Un procedimiento para preparar un compuesto de fórmula (1) con inclusión de sus enantiómeros o diastereómeros, que comprende: (a) hacer reaccionar un compuesto de fórmula (2) con hexametildisilazano para formar un compuesto de fórmula (3). (b) hacer reaccionar el compuesto de fórmula (3) con epihalohidrina y posterior hidrólisis del aducto resultante para formar un compuesto de fórmula (5); (c) hacer reaccionar el compuesto de fórmula (5) con amoníaco y posterior hidrólisis del resto de fosfinato de etilo para formar el compuesto de fórmula (1), y opcionalmente (d) convertir el compuesto de fórmula (1) en una sal farmacéuticamente aceptable, en la cual R es bencilo o ciclohexilmetilo, y X es halógeno.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50522003P | 2003-09-23 | 2003-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR045794A1 true AR045794A1 (es) | 2005-11-16 |
Family
ID=34392994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040103395A AR045794A1 (es) | 2003-09-23 | 2004-09-21 | Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7186705B2 (es) |
| EP (1) | EP1673377B1 (es) |
| JP (1) | JP4558732B2 (es) |
| AR (1) | AR045794A1 (es) |
| TW (1) | TW200526676A (es) |
| WO (1) | WO2005030781A1 (es) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8728483D0 (en) * | 1987-12-04 | 1988-01-13 | Ciba Geigy Ag | Chemical compounds |
| US5300679A (en) * | 1987-12-04 | 1994-04-05 | Ciba-Geigy Corporation | Substituted propane-phosphinic acid compounds |
| US5567840A (en) * | 1989-05-13 | 1996-10-22 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| IL114631A (en) * | 1990-06-22 | 1998-12-06 | Novartis Ag | Anti-epileptic compositions containing gabab- antagonistic compounds |
| EP0543780A3 (en) * | 1991-11-21 | 1993-09-01 | Ciba-Geigy Ag | Novel aminoalkanephosphinic acids and their salts |
| AU662404B2 (en) * | 1992-05-08 | 1995-08-31 | Novartis Ag | Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids |
-
2004
- 2004-09-21 AR ARP040103395A patent/AR045794A1/es not_active Application Discontinuation
- 2004-09-22 US US10/946,869 patent/US7186705B2/en not_active Expired - Lifetime
- 2004-09-22 EP EP04784690.2A patent/EP1673377B1/en not_active Expired - Lifetime
- 2004-09-22 WO PCT/US2004/030926 patent/WO2005030781A1/en not_active Ceased
- 2004-09-22 JP JP2006528105A patent/JP4558732B2/ja not_active Expired - Fee Related
- 2004-09-23 TW TW093128792A patent/TW200526676A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007506747A (ja) | 2007-03-22 |
| TW200526676A (en) | 2005-08-16 |
| WO2005030781A1 (en) | 2005-04-07 |
| US7186705B2 (en) | 2007-03-06 |
| EP1673377A1 (en) | 2006-06-28 |
| JP4558732B2 (ja) | 2010-10-06 |
| US20050070507A1 (en) | 2005-03-31 |
| EP1673377B1 (en) | 2013-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2637765A1 (en) | Benzamide and heteroarene derivatives | |
| AR031828A2 (es) | Procedimientos para la preparacion de compuestos espiro-azabiciclicos utiles en terapia | |
| BR0210071A (pt) | Composto, processo para preparar o mesmo, composição farmacêutica, uso de um composto, método para produzir um efeito inibitório de ciclo celular (anti-proliferação celular) em um animal de sangue quente | |
| SG148177A1 (en) | Novel cis-imidazolines | |
| UY26332A1 (es) | Nuevos derivados del ácido aminodicarboxílico con propiedades farmacéuticas. | |
| BR0212458A (pt) | Composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, composição farmacêutica, e, processo para a preparação de um composto ou sais farmaceuticamente aceitável, ou ésteres hidrolizáveis in vivo deste | |
| EA200970296A1 (ru) | Содержащие диариловый эфир соединения мочевины | |
| SE0100567D0 (sv) | Compounds | |
| PT1140745E (pt) | Derivados de colquinol como agentes de danificacao vascular | |
| IL192253A0 (en) | Substituted cyclohexylmethyl derivatives | |
| RU2009135621A (ru) | Хинолиновые производные для лечения воспалительных заболеваний | |
| WO2006034833A1 (en) | Cyclic diarly ureas suitable as tyrosine kinase inhibitors | |
| GEP20084376B (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
| SI1594885T1 (sl) | Zdravilo za inhibiranje rasti tumorjev | |
| RU2015122032A (ru) | Оксазолидинонсодержащие соединения, композиции и способы их использования | |
| GEAP202516737A (en) | Compounds for treating cancer | |
| MX2025010256A (es) | Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno | |
| EP4635494A3 (en) | AMIDO HETERO-ROMATIC COMPOUNDS | |
| GB0205688D0 (en) | Chemical compounds | |
| MX2023009166A (es) | Derivados de quinoxalina y sus usos. | |
| AR027578A1 (es) | Derivados de indano | |
| RU2007138582A (ru) | Пероральные дозированные формы производных гемцитабина | |
| AR011521A1 (es) | Un derivado de la prolil-3-(2-naftil) alanil-n-bencil-n-metilamida, un procedimiento para su preparacion y una composicion farmaceutica que lo comprende | |
| AR045794A1 (es) | Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico | |
| MY153733A (en) | Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |